Effect of olmesartan medoxomil on atherosclerosis: clinical implications of the emerging evidence. [electronic resource]
Producer: 20070329Description: 363-6 p. digitalISSN:- 1175-3277
- Angiotensin II Type 1 Receptor Blockers -- pharmacology
- Angiotensin-Converting Enzyme Inhibitors -- pharmacology
- Animals
- Atherosclerosis -- blood
- C-Reactive Protein -- metabolism
- Chemokine CCL2 -- blood
- Clinical Trials as Topic
- Humans
- Imidazoles -- pharmacology
- Interleukin-6 -- blood
- Olmesartan Medoxomil
- Tetrazoles -- pharmacology
- Tumor Necrosis Factor-alpha -- blood
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.